How has Safety Pharmacology done thus far?
November 19, 2008 Annual Meeting No CommentsThe SPS will be in its tenth year of existence in 2009 and safety pharmacology as a defined scientific enterprise is also about a decade old. Have we made an impact on the safety of drug development? How is safety pharmacology data viewed by our management in the pharmaceutical industry; are we giving good value for their investments? How are our data being received by regulators? Do we contribute effectively to the safety of early clinical trials? Is our data being taken seriously and is it thought to be predictive by the authorities?
The program committee for the 2009 annual meeting to be held in September in Strasbourg, France is contemplating organizing some programming that will examine this type of question. It should however not only give Safety Pharmacology a ten year “report card” but also look into the future for areas of improvement or expansion.
We’d love to get your input and ideas to give some content to these important questions to help guide us in identifying critical themes and finding appropriate speakers to address them. We may attempt either a panel discussion format or perhaps a debate setting, but regardless of how it turns out, we would appreciate your contribution!



